Use UniProt P54289 as the stable identity anchor, then attach disease evidence before program review.
CHEMBL4106164 Target Snapshot
L-type calcium channel alpha-1c/beta-2/alpha2delta-1 · PROTEIN COMPLEX · Homo sapiens
Research home keeps recent targets
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Switch target
Move to another high-traffic target or paste a specific ChEMBL target ID.
Frame the target before identity details
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Protein identity stays anchored to UniProt P54289. Use UniProt P54289 as the stable identity anchor, then attach disease evidence before program review.
Voltage-dependent calcium channel subunit alpha-2/delta-1
Review this target as L-type calcium channel alpha-1c/beta-2/alpha2delta-1, mapped to UniProt P54289. ChEMBL maps the protein component as Voltage-dependent calcium channel subunit alpha-2/delta-1. Sequence length is 1103 aa.
Protein source · UniProt accession via ChEMBL component mappingCross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats L-type calcium channel alpha-1c/beta-2/alpha2delta-1 as ChEMBL target CHEMBL4106164, mapped to UniProt P54289. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Start with the right source
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether L-type calcium channel alpha-1c/beta-2/alpha2delta-1 is the right protein anchor across sources, using UniProt P54289 as the stable mapping.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardBasic Information
Verify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | L-type calcium channel alpha-1c/beta-2/alpha2delta-1 |
| Target Type | PROTEIN COMPLEX |
| Organism | Homo sapiens |
| UniProt | P54289 |
Next Actions
UniProt Target Context
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | Voltage-dependent calcium channel subunit alpha-2/delta-1 |
| UniProt Accession | P54289 |
| Component Type | Protein |
| Sequence Length | 1103 aa |
Voltage-dependent calcium channel subunit alpha-2/delta-1
How to read this target
Review this target as L-type calcium channel alpha-1c/beta-2/alpha2delta-1, mapped to UniProt P54289. ChEMBL maps the protein component as Voltage-dependent calcium channel subunit alpha-2/delta-1. Sequence length is 1103 aa.
Clinical Phase Distribution
Activity Type Distribution
Top Inhibitors (by pChEMBL)
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL1428 | 7.53 | IC50 | 29.8 | Approved |
| CHEMBL71260 | 4.38 | IC50 | 41300.0 | Preclinical |
| CHEMBL4874732 | 4.17 | IC50 | 67300.0 | Preclinical |
pChEMBL Value Distribution
Approved Drugs
Assay Landscape
Binding — 6 assays, 3 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| cell-based format | 6 | 3 | 5.4 |
ADME — 1 assays, 0 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| cell-based format | 1 | 0 | — |
Toxicity — 1 assays, 0 compounds
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| cell-based format | 1 | 0 | — |